4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-23-004701
Options or other derivatives
- Chief Operating Officer acquired 144,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Longcor Jarrod Chief Operating Officer | 2023-01-17 | Grant or award · Stock option (right to buy) | +144,000 | 144,000 | D | ||
Loading xslF345X03/tm233841-3_4seq1.xml…